Sie sind hier: Startseite > News > Überblick: EU Ausschreibung im Health Programm FP7-HEALTH-2012 mit 32 Themen



Überblick: EU Ausschreibung im Health Programm FP7-HEALTH-2012 mit 32 Themen

FP7-HEALTH-2012 Themen:

HEALTH.2012.1.2-1: Development of technologies with a view to patient group stratification for personalised medicine applications.

HEALTH.2012.1.4-1: Innovative approaches to solid organ transplantation.

HEALTH.2012.1.4-2: Medical technology for transplantation and bioartificial organs.

HEALTH.2012.1.4-3: Innovative Strategies for translation of stem cell based therapies in regenerative medicine (European Union-Australia cooperation).

HEALTH.2012.1.4-4: Targeted nucleic acid delivery as an innovative therapeutic or prophylactic approach.

HEALTH.2012.2.1.1-1-B: Clinical utility of -omics for better diagnosis of rare diseases.

HEALTH.2012.2.1.1-1-C: Databases, biobanks and 'clinical bio-informatics' hub for rare diseases.

HEALTH.2012.2.1.1-2: Validation of -omics-based biomarkers for diseases affecting the elderly.

HEALTH.2012.2.1.1-3: Statistical methods for collection and analysis of -omics data.

HEALTH.2012.2.1.2-1: Systems medicine: SME-driven research applying systems biology approaches to address medical and clinical needs.

HEALTH.2012.2.1.2-2: Systems medicine: Applying systems biology approaches for understanding multifactorial human diseases and their co-morbidities.

HEALTH.2012.2.1.2-3: Preparing for the future research and innovation activities in systems medicine.

HEALTH.2012.2.2.2-1: Integrative systems biology and comparative genomics for studying human ageing and/or most common age-related diseases.

HEALTH.2012.2.2.2.-2: Investigator-driven clinical trials for optimisation of management of elderly patients with multiple diseases.

HEALTH.2012.2.3.0-1: Diagnostics for infectious diseases in humans.

HEALTH.2012.2.3.0-2: ERA-NET on infectious diseases.

HEALTH.2012.2.3.2-1: Co-infection of HIV/AIDS, malaria, tuberculosis and/or hepatitis.

HEALTH.2012.2.3.2-2: Co-morbidity between infectious and non-communicable disease.

HEALTH.2012.2.3.2-3: Prevention and treatment for HIV/AIDS, malaria and tuberculosis.

HEALTH.2012.2.3.2-4: Low-cost interventions for disease control in resource poor settings.

HEALTH.2012.2.4.3-1: Innovative approach to manage diabetes.

HEALTH.2012.2.4.3-2: Investigator-driven clinical trials for type 1 diabetes research.

HEALTH.2012.2.4.4-1: Preclinical and/or clinical development of substances with a clear potential as orphan drugs.

HEALTH.2012.2.4.4-2: Observational trials in rare diseases.

HEALTH.2012.2.4.4-3: Best practice and knowledge sharing in the clinical management of rare diseases.

HEALTH.2012.2.4.5-2: Biomarkers and diagnostics for chronic inflammatory diseases of the joints and/or digestive system.

HEALTH.2012.3.2-1: Improving the organisation of health service delivery.

HEALTH.2012.3.2-2: New methodologies for health technology assessment.

HEALTH.2012.3.2-3: Social innovation for ageing research.

Voraussichtliche Deadline 4. Oktober 2011

Überblick HEALTH-2012, Schwerpunkte und Kontaktdaten, englisch (pdf)

Weiter Informationen: